Projects funded by the NCN
Identification of new, clinically relevant genetic and epigenetic aberrations by next-generation sequencing in chronic myeloid leukemia patients with poor disease outcome
2014/14/M/NZ5/00441
Keywords:
chronic myeloid leukemia targeted therapy drug resistance blast crisis leukemic stem cells next-generation sequencing whole-exome and methylome sequencing synthetic lethality
Descriptors:
- NZ2_2: Genomics, transcriptomics, epigenomics
- NZ5_3: Pathogenesis of human diseases
- NZ2_1: Molecular genetics
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Warszawski Uniwersytet Medyczny, Wydział Lekarski
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 11
Call: HARMONIA 6 - announced on 2014-06-16
Amount awarded: 1 802 112 PLN
Project start date (Y-m-d): 2015-05-21
Project end date (Y-m-d): 2020-11-20
Project duration:: 66 months (the same as in the proposal)
Project status: Project settled